Cutting edge: Proangiogenic properties of alternatively activated dendritic cells

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 2788-2792

  Riboldi, Elena ^a   Musso, Tiziana ^b   Moroni, Emanuela ^a   Urbinati, Chiara ^a   Bernasconi, Sergio ^c   Rusnati, Marco ^a   Adorini, Luciano ^d   Presta, Marco ^a   Sozzani, Silvano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d BioXell SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYTOKINE; INTERLEUKIN 10; PROSTAGLANDIN E2; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL MATURATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 23844542702     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.2788     Document Type: Article

References (21)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Mantovani, A., S. Sozzani, M. Locaci, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
3. Goerdt, S., and C. E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142.
4. Strieter, R. M., J. A. Belperio, R. J. Phillips, and M. P. Keane. 2004. CXC chemokines in angiogenesis of cancer. Semin. Cancer Biol. 14: 195-200.
5. Frantz, S., K. A, Vincent, O. Feron, and R. A. Kelly. 2005. Innate immunity and angiogenesis, Circ. Res. 96: 15-26.
6. Vulcano, M., S. Dusi, D. Lissandrini, R. Badolato, P. Mazzi, E. Riboldi, E. Borroni, A. Calleri, M. Donini, A. Plebani, et al. 2004. Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J. Immunol. 173: 5749-5756.
7. Baldanzi, G., S. Mitola, S. Cutrupi, N. Filigheddu, W. J. van Blitterswijk, F. Sinigaglia, F. Bussolino, and A. Graziani. 2004. Activation of diacylglycerol kinase α is required for VEGF-induced angiogenic signaling in vitro. Oncogene 23: 4828-4838.
8. Leali, D., P. Dell'Era, H. Stabile, B. Sennino, A. F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta. 2003. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J. Immunol. 171: 1085-1093.
9. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411.
10. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, et al. 1986. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83: 4167-4171.
11. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
12. Ferrara, N., H. P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9: 669-676.
13. Singer, A. J., and R. A. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341: 738-746.
14. 1 in osteoblasts. J. Clin. Invest. 93: 2490-2496.
15. Falkenstein, E., H. C. Tillmann, M. Christ, M. Feuring, and M. Wehling. 2000. Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol. Rev. 52:513-556.
16. Regan, J. W. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74: 143-153.
17. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996, Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. [Published erratum appears in 1996 Nat. Med. 2: 1267.] Nat. Med. 2: 1096-1103.
18. Takahashi, A., K. Kono, F. Ichihara, H. Sugai, H. Fujii, and Y. Matsumoto. 2004. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol. Immunother. 53: 543-550.
19. Doyen, V., M. Rubio, D. Braun, T. Nakajima, J. Abe, H. Saito, G. Delespesse, and M. Sarfati. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198: 1277-1283.
20. Yamamura, M., R. L. Modlin, J. D. Ohmen, and R. L. Moy. 1993. Local expression of anti-inflammatory cytokines in cancer. J. Clin. Invest. 91: 1005-1010.
21. Adorini, L., N. Giarratana, and G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16: 127-134.